Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Baituxiao Botanical Formula: Product, Label and Evidence ProfileRepresentative category illustration – no product packaging is shown.Baituxiao Botanical Formula: Product, Label and Evidence Profile
Baituxiao is marketed as a botanical supplement for pet wellness, comfort, vitality and normal immune function. It is not an FDA-approved cancer drug, and the manufacturer's own disclaimer…
Read more
Prednisone in Canine Cancer Care: A Timing and Safety Discussion
Prednisone is a prescription corticosteroid used in several veterinary cancer contexts, including components of lymphoma protocols and selected palliative plans. Its purpose, timing and taper must be defined…
Read more
Multimodal Pain Management in Canine Cancer Care
Multimodal pain management combines approaches that act at different points in the pain pathway and addresses both the tumor and its functional consequences. A plan may include prescriptions,…
Read moreNamed profile Prednisolone in Feline and Canine Oncology: Uses and Safety BoundariesRepresentative category illustration – no product packaging is shown.Prednisolone in Feline and Canine Oncology: Uses and Safety Boundaries
prednisolone is covered as glucocorticoid with lympholytic, anti-inflammatory and supportive-care roles, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Temozolomide in Veterinary Oncology: Oral Alkylator and Evidence BoundaryRepresentative category illustration – no product packaging is shown.Temozolomide in Veterinary Oncology: Oral Alkylator and Evidence Boundary
temozolomide is covered as triazene antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Mitotane in Canine Adrenal Disease and Adrenocortical TumoursRepresentative category illustration – no product packaging is shown.Mitotane in Canine Adrenal Disease and Adrenocortical Tumours
mitotane (o,p′-DDD) is covered as adrenocorticolytic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease ProfileRepresentative category illustration – no product packaging is shown.Hydroxyurea in Veterinary Oncology: Myeloproliferative-Disease Profile
hydroxyurea is covered as ribonucleotide-reductase inhibitors; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety ProfileRepresentative category illustration – no product packaging is shown.Procarbazine in Veterinary Oncology: MOPP/LOPP Component and Safety Profile
procarbazine is covered as methylhydrazine antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History ProfileRepresentative category illustration – no product packaging is shown.Paclitaxel in Veterinary Oncology: Formulation and Regulatory-History Profile
paclitaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Docetaxel in Veterinary Oncology: Limited-Evidence Taxane ProfileRepresentative category illustration – no product packaging is shown.Docetaxel in Veterinary Oncology: Limited-Evidence Taxane Profile
docetaxel is covered as taxane antineoplastic agents; hazardous antineoplastic medicine, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more
Named profile COP / CVP Lymphoma Chemotherapy: Veterinary Protocol ProfileRepresentative category illustration – no product packaging is shown.COP / CVP Lymphoma Chemotherapy: Veterinary Protocol Profile
cyclophosphamide, vincristine (Oncovin) and prednisone or prednisolone is covered as multi-agent lymphoma chemotherapy protocol, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich ProtocolsRepresentative category illustration – no product packaging is shown.MOPP and LOPP for Canine Lymphoma: Distinct Alkylator-Rich Protocols
MOPP and LOPP multi-agent chemotherapy is covered as alkylator-rich canine lymphoma protocols, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more